TRAP® Discovered Pipeline of Small Molecule Drug Candidates
Therapeutic Area Mode of Action Status
Cancer Tetravalent Alkylator
Pre-IND Studies
  Dual Aurora-VEGFR kinase
IND Candidate Selection
  VEGFR2
In vivo Proof of Concept Achieved
    Tubulin In vivo Proof of Concept Achieved
Multiple Sclerosis Chemokine Out-licensed
Diabetes IRK
Out-licensed
 

For further licensing information, please contact:

Steven R. Schow, Ph.D.
Vice President, Research and Development
Telik, Inc.
2100 Geng Road, Suite 102
Palo Alto, CA 94303
Tel: +1 (650) 845-7700
Fax: +1 (650) 845-7800
E-Mail: BusinessDev@telik.com

 

Sitemap Contact Legal Notice Telik Home